Home › Funds › SUMITOMO MITSUI FINANCIAL GROUP, INC. › BSX
SUMITOMO MITSUI FINANCIAL GROUP, INC. position in BSX
BOSTON SCIENTIFIC CORP · Health Care
SUMITOMO MITSUI FINANCIAL GROUP, INC. reported holding 474,844 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q3 2026 13F filing — a position valued at US$20.7M, representing 0.44% of its reported portfolio and ranking #32 among its reported holdings. SUMITOMO MITSUI FINANCIAL GROUP, INC. has disclosed BSX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How SUMITOMO MITSUI FINANCIAL GROUP, INC.'s BSX position evolved
SUMITOMO MITSUI FINANCIAL GROUP, INC. first disclosed a stake in BSX in Q4 2024 at 150,810 shares (US$13.5M). The position peaked in Q3 2025 at 265,781 shares, worth US$25.9M. Across 8 filings, SUMITOMO MITSUI FINANCIAL GROUP, INC. increased the stake 7 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 474,844 shares valued at US$20.7M — an increase of 62,312 shares quarter over quarter.. Notable position changes include a 36% increase in Q1 2025 (shares rose 6% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 150.81K | $13.47M | New |
| Q1 2025 | 205.64K | $20.75M | Add |
| Q2 2025 | 235.48K | $25.29M | Add |
| Q3 2025 | 265.78K | $25.95M | Add |
| Q4 2025 | 269.88K | $25.73M | Add |
| Q1 2026 | 334.76K | $21.01M | Add |
| Q2 2026 | 412.53K | $17.61M | Add |
| Q3 2026 | 474.84K | $20.73M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BSX and 13F data
BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 18 other funds we track also report a position in BSX — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$2.56B), MFS Investment Management (US$2.29B), D. E. Shaw & Co (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BSX
- PRIMECAP MANAGEMENT CO/CA/ 58.62M sh · $2.56B · Q3 2026
- MFS Investment Management 43.05M sh · $2.29B · Q3 2026
- D. E. Shaw & Co 27.27M sh · $1.16B · Q2 2026
- Janus Henderson Group 16.50M sh · $1.04B · Q1 2026
- Arrowstreet Capital 23.29M sh · $994.18M · Q2 2026
More on SUMITOMO MITSUI FINANCIAL GROUP, INC.
FAQ
How long has SUMITOMO MITSUI FINANCIAL GROUP, INC. held BSX?
SUMITOMO MITSUI FINANCIAL GROUP, INC. has disclosed BSX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is SUMITOMO MITSUI FINANCIAL GROUP, INC.'s current position in BSX?
As of Q3 2026, SUMITOMO MITSUI FINANCIAL GROUP, INC. holds 474.84K shares of BSX (BOSTON SCIENTIFIC CORP), valued at $20.73M, representing 0.44% of its reported portfolio and ranking #32.
Has SUMITOMO MITSUI FINANCIAL GROUP, INC. been buying or selling BSX?
In the latest 13F filing (Q3 2026), SUMITOMO MITSUI FINANCIAL GROUP, INC. increased its position in BSX. The position peaked in Q3 2025 at 265.78K shares.
Which other funds hold BSX?
Other major institutional holders of BSX include PRIMECAP MANAGEMENT CO/CA/, MFS Investment Management, D. E. Shaw & Co, among 18 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.